Clinical Considerations for Use of SGLT2 Inhibitor Therapy in Patients with Heart Failure and Reduced Ejection Fraction: A Review

Jhalani, N. B. (2022). Clinical Considerations for Use of SGLT2 Inhibitor Therapy in Patients with Heart Failure and Reduced Ejection Fraction: A Review. Advances in Therapy, 39(8), 3472–3487. https://doi.org/10.1007/s12325-022-02169-3
Authors:
Nisha B Jhalani
Affiliated Authors:
Nisha B Jhalani
Author Keywords:
cardiovascular
heart failure
sodium–glucose cotransporter 2 inhibitors
type 2 diabetes
Publication Type:
Article
Unique ID:
10.1007/s12325-022-02169-3
PMID:
Publication Date:
Data Source:
PubMed

Record Created: